Brendan Smith
Nessuna posizione attualmente
Profilo
Attualmente, Brendan Smith ricopre la posizione di Senior VP, Chief Financial & Accounting Officer presso CRISPR Therapeutics AG. In passato Mr. Smith è stato Chief Financial Officer & Head-Corporate Strategy presso Translate Bio, Inc. e Partner & Associate Director presso The Boston Consulting Group, Inc. Si è laureato al Worcester Polytechnic Institute e ha conseguito un MBA alla Harvard Business School.
Precedenti posizioni note di Brendan Smith
| Società | Posizione | Fine |
|---|---|---|
| CRISPR THERAPEUTICS AG | Direttore Finanziario/CFO | 14/03/2023 |
| TRANSLATE BIO, INC. | Direttore Finanziario/CFO | 14/09/2021 |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01/03/2021 |
| Pfizer AG | Direttore/Membro del Consiglio | - |
Formazione di Brendan Smith
| Worcester Polytechnic Institute | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CRISPR THERAPEUTICS AG | Health Technology |
| Aziende private | 3 |
|---|---|
Translate Bio, Inc.
 Translate Bio, Inc. BiotechnologyHealth Technology Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidate, MRT5005 is designed for the treatment of cystic fibrosis. The company was founded by Arthur M. Krieg and Jeannie T. Lee in 2011 and is headquartered in Lexington, MA. | Health Technology |
The Boston Consulting Group, Inc.
The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Commercial Services |
| Pfizer AG |
- Borsa valori
- Insiders
- Brendan Smith
